Navigation Links
PTC Therapeutics Announces Additional Results from Phase 2 Study of PTC124 in Duchenne Muscular Dystrophy
Date:10/18/2007

le improvement in the staining for dystrophin from muscle biopsies. Response did not appear to be dependent on type of nonsense mutation.

Blood levels of muscle-derived creatine kinase were also measured as assessments of muscle integrity. Statistically significant reductions in the concentrations of muscle-derived creatine kinase were observed during PTC124 treatment. In addition, several parents and teachers reported that boys participating in the study had improvements in terms of greater activity level and increased endurance during the study duration.

"We are very encouraged by these results, which show improvements in critical biomarkers of DMD," said presenter and study investigator, Carsten Bonnemann, M.D., Assistant Professor Neurology and Pediatrics, Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine and Co-Director of the Neuromuscular Program, Children's Hospital of Philadelphia. "The combined in vitro and in vivo evidence of enhanced dystrophin expression and reduced muscle fragility offer signals of pharmacological activity that we hope to translate into potential clinical benefit for patients with DMD."

"Coupled with the emerging safety profile of PTC124, these data provide the impetus for moving forward rapidly to initiate longer-term studies for boys with DMD," said Langdon Miller, M.D., Chief Medical Officer of PTC. "We are actively working with our clinical investigators and the regulatory agencies to finalize plans for additional clinical trials and we look forward to commencing these studies in the coming months."

Stuart W. Peltz, Ph.D., President and Chief Executive Officer of PTC Therapeutics added, "These results, combined with the data presented earlier this month at the Child Neurology Society meeting and North American Cystic Fibrosis Conference, further support our belief that PTC124 represents a paradigm shift in the treatment of genetic disorders. Our future plans for PTC124 inc
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
9. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 11, 2014 Patient engagement has become ... organizations are turning to an assortment of marketing ... part of this evolving approach to patient engagement, ... and engage patients throughout their experiences with a ... By mapping the patient journey and employing a ...
(Date:7/11/2014)... 11, 2014  Rock Creek Pharmaceuticals, Inc. (NASDAQ: ... that the Food and Drug Administration ("FDA"), has notified ... RCP,s Investigational New Drug ("IND") application before granting the ... US. Dr. Chris Chapman , RCP,s ... on our IND. When we receive the agency,s official ...
(Date:7/11/2014)... DALLAS , July 11, 2014 ... report "Scintillator Market by Composition of Material, Application ... and others), End Product (Personal Instrument, Hand-Held Instruments, ... Forecast and Analysis to 2013 - 2020", published by MarketsandMarkets, ... a CAGR of 5.62% from 2014 to 2020, ...
Breaking Medicine Technology:New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Rock Creek Pharmaceuticals Issues Update On US Investigational New Drug Application 2Scintillator Market will be worth $479.16 Million by 2020 2Scintillator Market will be worth $479.16 Million by 2020 3Scintillator Market will be worth $479.16 Million by 2020 4
... , , , ... (Nasdaq: AMGN ) today announced the publication of results from ... at reducing fracture risk in more than 7,800 women with postmenopausal osteoporosis ... deprivation therapy (ADT) leading to bone loss. In both studies, published today ...
... , , , ... BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that the ... chronically infected with the hepatitis C virus (HCV). The trial, run in ... clemizole monotherapy in the absence of interferon. , , ...
Cached Medicine Technology:Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 2Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 3Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 4Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 5Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 6Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 7Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 8Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 9Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 10Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss 11Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial 2Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial 3
(Date:7/11/2014)... Miriam Hospital have found that people with mobility ... of smoking than those without mobility impairments. Additionally, ... attempt quitting than those without mobility impairments, and ... this population. The study and its findings are ... American Journal of Public Health . ...
(Date:7/11/2014)... has found that organic foods and crops have ... including more antioxidants and fewer, less frequent pesticide ... 343 peer-reviewed publications comparing the nutritional quality and ... fruits, vegetables, and grains. The study team applied ... and non-organic foods. , "Science marches on," ...
(Date:7/11/2014)... Delaying surgery to repair damage to the anterior cruciate ligament ... knee -- could increase a young athlete,s risk for further ... 130 patients, aged 8 to 16, who had ACL reconstruction ... weeks after their injury, 37 had surgery six to 12 ... months after their injury. The youngsters who had surgery ...
(Date:7/11/2014)... Prostate cancer patients are more likely to be diagnosed ... sooner if they also have depression, a new study ... American men who were diagnosed with localized prostate cancer ... Nearly 1,900 of the patients had been diagnosed with ... was discovered. "Men with intermediate- or high-risk prostate ...
(Date:7/11/2014)... Ticket Down is a reliable ... Train Amphitheatre in Wheatland, CA. In the Sacramento ... what the Sleep Train Amphitheatre can do for music fans. ... over the course of its existence and can seat 18,500 ... in Wheatland (Sacramento metro area) will host the “That’s My ...
Breaking Medicine News(10 mins):Health News:Miriam Hospital study examines smoking prevalence 2Health News:Major study documents nutritional and food safety benefits of organic farming 2Health News:Major study documents nutritional and food safety benefits of organic farming 3Health News:Delaying Kid's Knee Surgery Could Be a Bad Play, Study Finds 2Health News:Depression May Make It Harder to Beat Prostate Cancer 2Health News:Luke Bryan Tickets Sleep Train Amphitheatre in Wheatland, CA (Sacramento): Ticket Down has Slashed Ticket Prices on Luke Bryan in Wheatland at Sleep Train 2Health News:Luke Bryan Tickets Sleep Train Amphitheatre in Wheatland, CA (Sacramento): Ticket Down has Slashed Ticket Prices on Luke Bryan in Wheatland at Sleep Train 3
... of refugees settled in the makeshift relief camps of ... of Chhattisgarh.// ,UNICEF will specifically look into ... settled in these camps. ,According to ... the organisation's representative in India, met Chhattisgarh chief minister ...
... towards water to chill out. Places such as backyard pool, hot ... very for cautious and always follow the instructions of their parents. ... all the safety measures such as installing the pool fences and ... fail to install the child proof safety measures as it is ...
... gay men who have also been diagnosed as HIV-positive seemed ... status to others//. ,The study, the first of ... HIV-positive men who are often uncertain whether to tell friends, ... that causes AIDS. It was published in the April issue ...
... fees for admittance into various medical courses offered by ... education and research department// of the Punjab government. The ... medical and paramedical courses. ,Representatives of medical ... consultation regarding the actual fees to be fixed for ...
... in which the sinuses become inflamed or infected affecting ... conventional surgery//. But now Acclarent has come up with ... a small balloon in the sinus cavity which clears ... breakthrough that offers hope to many sinusitis sufferers. It ...
... High Court has sought an explanation from medical superintendent ... disclosure of sufficient details after a boy, suffering from ... the hospital in 2001. ,Aggrieved with the ... the hospital to explain its unwillingness to disclose details ...
Cached Medicine News:Health News:Hot Tubs and Spas in the News for Safety Measures 2Health News:Gays Have No Regrets 2Health News:Gays Have No Regrets 3Health News:Provisional Fees For Medical Courses Fixed By Punjab Government 2Health News:Teething Problems of Sinuplasty 2
Standard general retractor system. Fully-adjustable to maintain a low profile in any approach and any patient. Blades can be stacked on top of each other in the operative site....
These retractors are packaged singly ready for sterilization at your facility....
... Pipetman Concept is a revolutionary ... and flexibility in mind, Pipetman Concept ... direct pipette-to-PC connectionthe only one of ... used with Diamond Tips from Gilson, ...
... 3 - Vivid family system designed to ... cardiovascular performance, and offer an even wider ... and the OR. , ,From color flow ... connectivity, the new Vivid 3 offers a ...
Medicine Products: